D.E. Shaw & Co
SLXP

D.E. Shaw & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

D.E. Shaw & Co’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-258,455
Closed -$44.7M – 4047
2015
Q1 		$44.7M Buy
258,455
+256,375
+12,326% +$37.6M 0.07% 339
2014
Q4 		$239K Sell
2,080
-19,304
-90% -$2.34M ﹤0.01% 3741
2014
Q3 		$3.34M Buy
+21,384
New +$3.1M ﹤0.01% 1831
2014
Q2 		– Sell
-19,084
Closed -$2.11M – 4835
2014
Q1 		$1.98M Sell
19,084
-283,111
-94% -$29M ﹤0.01% 2409
2013
Q4 		$27.2M Buy
302,195
+70,265
+30% +$5.6M 0.04% 531
2013
Q3 		$15.5M Sell
231,930
-217,538
-48% -$15M 0.02% 716
2013
Q2 		$29.7M Buy
+449,468
New +$25.7M 0.06% 377

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's SLXP Position: Q2 2015 in Review

D.E. Shaw & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 258,455 shares — an estimated $44.7M sold.

D.E. Shaw & Co first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $44.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • D.E. Shaw & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 258,455 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.7M.
  • D.E. Shaw & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
  • D.E. Shaw & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.7M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.